Hyperliquid has introduced the HIP-3 framework, allowing third-party deployers to create perpetual decentralized exchange (DEX) markets. The first three assets on each perp DEX do not require auctions, but additional assets use a shared Dutch auction system. Each deployer manages their own market settings and oracles, and order books remain specific to each perp DEX. The framework clarifies that a ticker symbol alone, such as MELI for MercadoLibre, does not confirm an active perpetual market for that asset.
The Hyperliquid HIP-3 framework for perpetual decentralized exchange markets is the subject, with Pluang market data providing context. For readers following major cryptocurrencies on Pluang as of Nov 02, 2026 19:42 WIB: breadth showed 7 rising and 42 falling among 50 assets. EOS gained 8.13% to Rp12.649 with a typical hold time of 87 days, contrasting with BAT which dropped 5.58% to Rp2.394 and saw 73% sell activity, and CRV down 4.46% at Rp4.969 with 57% sell orders and a shorter hold time of 62 days.
The global bio-based construction polymer market, valued at $18.2 billion in 2025, is projected to grow to $35 billion by 2033 at an 8.3% CAGR. Growth is fueled by rising demand for sustainable building materials that reduce greenhouse gas emissions ...
Annual Over-the-Air (OTA) software updates for software-defined vehicles (SDVs) are projected to reach over 2 billion globally by 2035, up from 546 million in 2025, driven by rising SDV sales and advanced vehicle software platforms. Level 3 and above...
Fram Wind Solutions AS, a joint venture partly owned by BW Offshore, secured a NOK 1.94 billion grant from Enova to develop a floating offshore wind project featuring two 18.5 MW turbines, the largest globally, with a combined capacity of 37 MW. The ...
Thailand's textile market is projected to grow from USD 4.97 billion in 2026 to USD 5.39 billion by 2032, at a CAGR of 1.31%. Growth is fueled by domestic fiber production, machinery upgrades, and rising demand for faster garment replenishment, espec...
Callan JMB has received and will install a QuickStrip™ oral thin-film production line from Rapid Dose Therapeutics at its Texas facility, marking a key step in expanding its domestic pharmaceutical manufacturing. This new capability aims to produce f...
